222 related articles for article (PubMed ID: 28780411)
1. Increased ethanol drinking in "humanized" mice expressing the mu opioid receptor A118G polymorphism are mediated through sex-specific mechanisms.
Henderson-Redmond AN; Lowe TE; Tian XB; Morgan DJ
Brain Res Bull; 2018 Apr; 138():12-19. PubMed ID: 28780411
[TBL] [Abstract][Full Text] [Related]
2. A pharmacogenetic determinant of mu-opioid receptor antagonist effects on alcohol reward and consumption: evidence from humanized mice.
Bilbao A; Robinson JE; Heilig M; Malanga CJ; Spanagel R; Sommer WH; Thorsell A
Biol Psychiatry; 2015 May; 77(10):850-8. PubMed ID: 25442002
[TBL] [Abstract][Full Text] [Related]
3. Morphine-induced antinociception and reward in "humanized" mice expressing the mu opioid receptor A118G polymorphism.
Henderson-Redmond AN; Yuill MB; Lowe TE; Kline AM; Zee ML; Guindon J; Morgan DJ
Brain Res Bull; 2016 May; 123():5-12. PubMed ID: 26521067
[TBL] [Abstract][Full Text] [Related]
4. Heroin-induced suppression of saccharin intake in OPRM1 A118G mice.
Freet CS; Alexander DN; Imperio CG; Ruiz-Velasco V; Grigson PS
Brain Res Bull; 2018 Apr; 138():73-79. PubMed ID: 28939474
[TBL] [Abstract][Full Text] [Related]
5. Receptor Reserve Moderates Mesolimbic Responses to Opioids in a Humanized Mouse Model of the OPRM1 A118G Polymorphism.
Robinson JE; Vardy E; DiBerto JF; Chefer VI; White KL; Fish EW; Chen M; Gigante E; Krouse MC; Sun H; Thorsell A; Roth BL; Heilig M; Malanga CJ
Neuropsychopharmacology; 2015 Oct; 40(11):2614-22. PubMed ID: 25881115
[TBL] [Abstract][Full Text] [Related]
6. Cocaine-induced suppression of saccharin intake and morphine modulation of Ca²⁺ channel currents in sensory neurons of OPRM1 A118G mice.
Freet CS; Ballard SM; Alexander DN; Cox TA; Imperio CG; Anosike N; Carter AB; Mahmoud S; Ruiz-Velasco V; Grigson PS
Physiol Behav; 2015 Feb; 139():216-23. PubMed ID: 25449401
[TBL] [Abstract][Full Text] [Related]
7. Opioid Antagonists and the A118G Polymorphism in the μ-Opioid Receptor Gene: Effects of GSK1521498 and Naltrexone in Healthy Drinkers Stratified by OPRM1 Genotype.
Ziauddeen H; Nestor LJ; Subramaniam N; Dodds C; Nathan PJ; Miller SR; Sarai BK; Maltby K; Fernando D; Warren L; Hosking LK; Waterworth D; Korzeniowska A; Win B; Richards DB; Vasist Johnson L; Fletcher PC; Bullmore ET
Neuropsychopharmacology; 2016 Oct; 41(11):2647-57. PubMed ID: 27109624
[TBL] [Abstract][Full Text] [Related]
8. Pharmacological consequence of the A118G μ opioid receptor polymorphism on morphine- and fentanyl-mediated modulation of Ca²⁺ channels in humanized mouse sensory neurons.
Mahmoud S; Thorsell A; Sommer WH; Heilig M; Holgate JK; Bartlett SE; Ruiz-Velasco V
Anesthesiology; 2011 Nov; 115(5):1054-62. PubMed ID: 21926562
[TBL] [Abstract][Full Text] [Related]
9. Effects of naltrexone on alcohol sensitivity and genetic moderators of medication response: a double-blind placebo-controlled study.
Ray LA; Hutchison KE
Arch Gen Psychiatry; 2007 Sep; 64(9):1069-77. PubMed ID: 17768272
[TBL] [Abstract][Full Text] [Related]
10. A gene-by-sex interaction for nicotine reward: evidence from humanized mice and epidemiology.
Bernardi RE; Zohsel K; Hirth N; Treutlein J; Heilig M; Laucht M; Spanagel R; Sommer WH
Transl Psychiatry; 2016 Jul; 6(7):e861. PubMed ID: 27459726
[TBL] [Abstract][Full Text] [Related]
11. A pharmacogenetic model of naltrexone-induced attenuation of alcohol consumption in rhesus monkeys.
Vallender EJ; Rüedi-Bettschen D; Miller GM; Platt DM
Drug Alcohol Depend; 2010 Jun; 109(1-3):252-6. PubMed ID: 20153935
[TBL] [Abstract][Full Text] [Related]
12. Genetic variation in the behavioral effects of buprenorphine in female mice derived from a murine model of the OPRM1 A118G polymorphism.
Browne CA; Erickson RL; Blendy JA; Lucki I
Neuropharmacology; 2017 May; 117():401-407. PubMed ID: 28188737
[TBL] [Abstract][Full Text] [Related]
13. Cholinergic mu-opioid receptor deletion alters reward preference and aversion-resistance.
Beane CR; Lewis DG; Bruns Vi N; Pikus KL; Durfee MH; Zegarelli RA; Perry TW; Sandoval O; Radke AK
Neuropharmacology; 2024 Sep; 255():110019. PubMed ID: 38810926
[TBL] [Abstract][Full Text] [Related]
14. Interacting effects of naltrexone and OPRM1 and DAT1 variation on the neural response to alcohol cues.
Schacht JP; Anton RF; Voronin KE; Randall PK; Li X; Henderson S; Myrick H
Neuropsychopharmacology; 2013 Feb; 38(3):414-22. PubMed ID: 23032071
[TBL] [Abstract][Full Text] [Related]
15. Murine model of OPRM1 A118G alters oxycodone self-administration and locomotor activation, but not conditioned place preference.
Collins D; Zhang Y; Blendy J; Kreek MJ
Neuropharmacology; 2020 May; 167():107864. PubMed ID: 31778689
[TBL] [Abstract][Full Text] [Related]
16. The Novel μ-Opioid Receptor Antagonist GSK1521498 Decreases Both Alcohol Seeking and Drinking: Evidence from a New Preclinical Model of Alcohol Seeking.
Giuliano C; Goodlett CR; Economidou D; García-Pardo MP; Belin D; Robbins TW; Bullmore ET; Everitt BJ
Neuropsychopharmacology; 2015 Dec; 40(13):2981-92. PubMed ID: 26044906
[TBL] [Abstract][Full Text] [Related]
17. Mu opioid receptors in GABAergic neurons of the forebrain promote alcohol reward and drinking.
Ben Hamida S; Boulos LJ; McNicholas M; Charbogne P; Kieffer BL
Addict Biol; 2019 Jan; 24(1):28-39. PubMed ID: 29094432
[TBL] [Abstract][Full Text] [Related]
18. The OPRM1 A118G polymorphism: converging evidence against associations with alcohol sensitivity and consumption.
Sloan ME; Klepp TD; Gowin JL; Swan JE; Sun H; Stangl BL; Ramchandani VA
Neuropsychopharmacology; 2018 Jun; 43(7):1530-1538. PubMed ID: 29497164
[TBL] [Abstract][Full Text] [Related]
19. Association of a functional polymorphism in the mu-opioid receptor gene with alcohol response and consumption in male rhesus macaques.
Barr CS; Schwandt M; Lindell SG; Chen SA; Goldman D; Suomi SJ; Higley JD; Heilig M
Arch Gen Psychiatry; 2007 Mar; 64(3):369-76. PubMed ID: 17339526
[TBL] [Abstract][Full Text] [Related]
20. Suppression of alcohol preference by naltrexone in the rhesus macaque: a critical role of genetic variation at the micro-opioid receptor gene locus.
Barr CS; Chen SA; Schwandt ML; Lindell SG; Sun H; Suomi SJ; Heilig M
Biol Psychiatry; 2010 Jan; 67(1):78-80. PubMed ID: 19748082
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
